BOULDER, Colo. (AP) — BOULDER, Colo. (AP) — Fresh Tracks Therapeutics, Inc. (FRTX) on Friday reported a loss of $2.3 million in its second quarter.

The Boulder, Colorado-based company said it had a loss of 39 cents per share.

The drug developer posted revenue of $53,000 in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FRTX at https://www.zacks.com/ap/FRTX

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News